These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12941339)

  • 1. 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).
    Hollick JJ; Golding BT; Hardcastle IR; Martin N; Richardson C; Rigoreau LJ; Smith GC; Griffin RJ
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3083-6. PubMed ID: 12941339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
    Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
    J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.
    Leahy JJ; Golding BT; Griffin RJ; Hardcastle IR; Richardson C; Rigoreau L; Smith GC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6083-7. PubMed ID: 15546735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.
    Griffin RJ; Fontana G; Golding BT; Guiard S; Hardcastle IR; Leahy JJ; Martin N; Richardson C; Rigoreau L; Stockley M; Smith GC
    J Med Chem; 2005 Jan; 48(2):569-85. PubMed ID: 15658870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.
    Willmore E; de Caux S; Sunter NJ; Tilby MJ; Jackson GH; Austin CA; Durkacz BW
    Blood; 2004 Jun; 103(12):4659-65. PubMed ID: 15010369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
    Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
    J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
    Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
    J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
    Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW
    Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase.
    Izzard RA; Jackson SP; Smith GC
    Cancer Res; 1999 Jun; 59(11):2581-6. PubMed ID: 10363977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinase.
    Barbeau OR; Cano-Soumillac C; Griffin RJ; Hardcastle IR; Smith GC; Richardson C; Clegg W; Harrington RW; Golding BT
    Org Biomol Chem; 2007 Aug; 5(16):2670-7. PubMed ID: 18019542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, crystal structure determination, and biological properties of the DNA-dependent protein kinase (DNA-PK) inhibitor 3-cyano-6-hydrazonomethyl-5-(4-pyridyl)pyrid-[1H]-2-one (OK-1035).
    Stockley M; Clegg W; Fontana G; Golding BT; Martin N; Rigoreau LJ; Smith GC; Griffin RJ
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2837-41. PubMed ID: 11597411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives.
    Clapham KM; Rennison T; Jones G; Craven F; Bardos J; Golding BT; Griffin RJ; Haggerty K; Hardcastle IR; Thommes P; Ting A; Cano C
    Org Biomol Chem; 2012 Sep; 10(33):6747-57. PubMed ID: 22814419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.
    Hardcastle IR; Cockcroft X; Curtin NJ; El-Murr MD; Leahy JJ; Stockley M; Golding BT; Rigoreau L; Richardson C; Smith GC; Griffin RJ
    J Med Chem; 2005 Dec; 48(24):7829-46. PubMed ID: 16302822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer.
    Kashishian A; Douangpanya H; Clark D; Schlachter ST; Eary CT; Schiro JG; Huang H; Burgess LE; Kesicki EA; Halbrook J
    Mol Cancer Ther; 2003 Dec; 2(12):1257-64. PubMed ID: 14707266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modulating effect of ATM, ATR, DNA-PK inhibitors on the cytotoxicity and genotoxicity of benzo[a]pyrene in human hepatocellular cancer cell line HepG2.
    Stępnik M; Spryszyńska S; Smok-Pieniążek A; Ferlińska M; Roszak J; Nocuń M
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):988-96. PubMed ID: 26595742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.
    Cano C; Saravanan K; Bailey C; Bardos J; Curtin NJ; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Menear KA; Newell DR; Richardson CJ; Shea K; Smith GC; Thommes P; Ting A; Griffin RJ
    J Med Chem; 2013 Aug; 56(16):6386-401. PubMed ID: 23855836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family.
    Chiosis G; Rosen N; Sepp-Lorenzino L
    Bioorg Med Chem Lett; 2001 Apr; 11(7):909-13. PubMed ID: 11294389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-dependent protein kinase and related proteins.
    Smith GC; Divecha N; Lakin ND; Jackson SP
    Biochem Soc Symp; 1999; 64():91-104. PubMed ID: 10207623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Judicious application of allyl protecting groups for the synthesis of 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl triflate, a key precursor of DNA-dependent protein kinase inhibitors.
    Aristegui SR; El-Murr MD; Golding BT; Griffin RJ; Hardcastle IR
    Org Lett; 2006 Dec; 8(26):5927-9. PubMed ID: 17165896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.